Physician profile
Erin E Riggle
NPI 1003004771
$25,455.15
in general payments reported to CMS, 2019-2025
56 companies · $3,184 in 2025
The $3,184 reported for 2025 was more than what 90% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,296 · 2020: $1,268 · 2021: $1,238 · 2022: $2,287 · 2023: $15K · 2024: $1,539 · 2025: $3,184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $7,385 · Travel and Lodging: $88.44 · Education: $43.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,850.00 |
| Food and Beverage | $7,384.94 |
| Travel and Lodging | $88.44 |
| Education | $43.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $13,196.36 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals LP | $2,636.42 | 2019-2025 | Breztri, Fasenra, Tagrisso |
| Glaxosmithkline, LLC. | $1,579.41 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| United Therapeutics Corporation | $845.76 | 2019-2025 | Tyvaso, Tyvaso |
| Genzyme Corporation | $794.12 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $730.20 | 2019-2025 | Ofev, Jascayd |
| Regeneron Healthcare Solutions, INC. | $627.85 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $580.85 | 2019-2025 | Prolastin-C Liquid |
| Bayer Healthcare Pharmaceuticals INC. | $533.77 | 2019-2025 | |
| Abiomed | $414.69 | 2019-2023 | Impella |
| Merck Sharp & Dohme LLC | $319.61 | 2019-2025 | Winrevair, Zerbaxa, Recarbrio |
| E.R. Squibb & Sons, L.L.C. | $254.05 | 2019-2024 | Eliquis |
| Actelion Pharmaceuticals US, INC. | $247.38 | 2020-2025 | Opsumit |
| Mylan Specialty L.P. | $233.33 | 2019-2024 | Yupelri |
| Janssen Pharmaceuticals, INC | $195.22 | 2019-2022 |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $192.80 | 2020-2025 | |
| Lilly USA, LLC | $168.90 | 2025 | Zepbound, Mounjaro |
| Takeda Pharmaceuticals U.S.A., INC. | $167.42 | 2022-2025 | Glassia, Hyqvia |
| Intuitive Surgical, INC. | $134.16 | 2024 | |
| Insmed, INC. | $131.26 | 2022-2025 | Arikayce, Brinsupri |
| Baxter Healthcare | $107.65 | 2023 | Hillrom - Life 2000 Ventilation System |
| Amgen INC. | $106.15 | 2023-2025 | Tezspire, Lumakras |
| Alexion Pharmaceuticals, INC. | $99.27 | 2020-2025 | Ultomiris |
| Mallinckrodt Hospital Products INC. | $93.15 | 2020-2025 | Acthar |
| Avadel Cns Pharmaceuticals, LLC | $68.05 | 2024-2025 | Lumryz |
| Gilead Sciences, INC. | $66.64 | 2022-2024 | |
| Pfizer INC. | $60.12 | 2025 | |
| Aerin Medical INC. | $57.05 | 2024 | |
| Medtronic Vascular, INC. | $53.09 | 2019 | |
| Genentech USA, INC. | $52.58 | 2019-2022 | |
| Caris Mpi, INC. | $49.46 | 2025 | Mi Cancer Seek |
| Sanofi Pasteur INC. | $48.32 | 2025 | |
| Sunovion Pharmaceuticals INC. | $46.97 | 2019 | |
| Inspire Medical Systems, INC. | $46.46 | 2024 | Inspire |
| Optinose US, INC. | $40.44 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $39.86 | 2021-2022 | |
| Abbvie INC. | $38.17 | 2023-2024 | Teflaro |
| Boston Scientific Corporation | $34.88 | 2022 | |
| Novartis Pharmaceuticals Corporation | $34.64 | 2019-2023 | |
| Jazz Pharmaceuticals INC. | $30.45 | 2025 | |
| Electromed, INC. | $25.19 | 2025 | Smartvest |
| Axsome Therapeutics, INC. | $25.07 | 2023 | Sunosi |
| Sandoz INC. | $24.42 | 2023 | Treprostinil |
| Ars Pharmaceuticals Operations, INC. | $23.13 | 2025 | Neffy |
| Intersect Ent, INC. | $22.49 | 2020 | |
| Zoll Respicardia, INC. | $20.17 | 2023 | Remede System |
| 3b Medical, INC. | $20.07 | 2025 | Luna |
| Tetraphase Pharmaceuticals, INC. | $18.00 | 2019 | |
| Idorsia Pharmaceuticals US INC | $17.76 | 2023 | Quviviq |
| Pulmonx Corporation | $17.75 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Shire North American Group INC | $16.48 | 2019 | |
| Portola Pharmaceuticals, LLC | $15.97 | 2019 | |
| Olympus America INC. | $14.74 | 2020 | |
| Circassia INC. | $13.47 | 2021 | |
| Philips North America LLC | $12.00 | 2020 | |
| Mission Pharmacal Company | $11.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Riggle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.